mannitol has been researched along with cimetidine in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (8.70) | 18.7374 |
| 1990's | 5 (21.74) | 18.2507 |
| 2000's | 8 (34.78) | 29.6817 |
| 2010's | 8 (34.78) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Artursson, P; Luthman, K; Norinder, U; Stenberg, P | 1 |
| Huang, L; Humphreys, JE; Morgan, JB; Polli, JW; Serabjit-Singh, CS; Webster, LO; Wring, SA | 1 |
| Artursson, P; Bergström, CA; Matsson, P; Nagahara, N; Norinder, U; Tavelin, S | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Barber, S; Dew, TP; Farrell, TL; Poquet, L; Williamson, G | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Ishida, M; Kondo, S; Maeba, T; Maeda, A | 1 |
| Ellis, D; Galvis, AG; Gartner, JC | 1 |
| Horwitz, LD; Myers, JH | 1 |
| Adkin, DA; Davis, SS; Huckle, PD; Sparrow, RA; Wilding, IR | 1 |
| Ayrton, J; Collett, A; He, YL; Rowland, M; Sims, E; Walker, D; Warhurst, G | 1 |
| Hatakeyama, Y; Saitoh, H; Sasaya, M; Takada, M | 1 |
| Atanassova, M; Kirkova, M; Russanov, E | 1 |
| Hashimoto, Y; Inui, KI; Katsura, T; Mizuuchi, H | 1 |
| Crespi, CL; Fox, L; Hu, M; Steimel, DT; Stocker, P | 1 |
| Grossouw, D; Krul, CA; van de Steeg, E; Verwei, M; Westerhout, J; Wortelboer, HM; Zeijdner, EE | 1 |
1 review(s) available for mannitol and cimetidine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for mannitol and cimetidine
| Article | Year |
|---|---|
The effect of mannitol on the oral bioavailability of cimetidine.
Topics: Administration, Oral; Adult; Anti-Ulcer Agents; Biological Availability; Cimetidine; Cross-Over Studies; Humans; Male; Mannitol; Solutions; Sucrose; Tablets | 1995 |
21 other study(ies) available for mannitol and cimetidine
| Article | Year |
|---|---|
Experimental and computational screening models for the prediction of intestinal drug absorption.
Topics: Biological Transport; Carbon Radioisotopes; Cell Line; Cell Membrane; Cell Membrane Permeability; Ciprofloxacin; Computational Biology; Drug Design; Foscarnet; Humans; Hydrogen Bonding; Intestinal Absorption; Intestinal Mucosa; Lactulose; Mannitol; Models, Biological; Raffinose; Surface Properties; Tritium; Verapamil | 2001 |
Rational use of in vitro P-glycoprotein assays in drug discovery.
Topics: Adenosine Triphosphatases; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cells, Cultured; Chromatography, Liquid; Enzyme Inhibitors; Fluoresceins; Fluorescent Dyes; Humans; Mass Spectrometry; Pharmacology; Spodoptera | 2001 |
Exploring the role of different drug transport routes in permeability screening.
Topics: Administration, Oral; Biological Transport; Caco-2 Cells; Cell Line; Humans; Intestinal Absorption; Intestinal Mucosa; Intestine, Small; Membranes, Artificial; Models, Biological; Molecular Conformation; Monte Carlo Method; Permeability; Pharmaceutical Preparations; Pharmacokinetics | 2005 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Predicting phenolic acid absorption in Caco-2 cells: a theoretical permeability model and mechanistic study.
Topics: Artificial Intelligence; Caco-2 Cells; Cell Membrane Permeability; Cinnamates; Enterocytes; Humans; Hydrophobic and Hydrophilic Interactions; Intestinal Absorption; Kinetics; Models, Biological; Molecular Conformation; Osmolar Concentration; Phenols | 2012 |
[Acute renal failure associated with miscellaneous drugs].
Topics: Acute Kidney Injury; Angiotensin-Converting Enzyme Inhibitors; Cimetidine; Furosemide; Humans; Lithium; Lovastatin; Mannitol; Methoxyflurane; Phenytoin; Rhabdomyolysis | 1991 |
Acute renal failure in infants and children: diagnosis, complications, and treatment.
Topics: Acidosis; Acute Kidney Injury; Age Factors; Amino Acids, Essential; Anti-Bacterial Agents; Burns; Child; Cimetidine; Creatinine; Electrolytes; Energy Intake; Enteral Nutrition; Furosemide; Hemoglobinuria; Humans; Infant; Infant, Low Birth Weight; Infant, Newborn; Kidney; Mannitol; Myoglobinuria; Peritoneal Dialysis; Poisoning; Postoperative Complications; Radionuclide Imaging; Renal Dialysis; Water-Electrolyte Balance | 1981 |
Ethanol-induced alterations in pancreatic blood flow in conscious dogs.
Topics: Animals; Cimetidine; Dogs; Ethanol; Mannitol; Meclofenamic Acid; Pancreas; Pancreatitis; Phenoxybenzamine; Propranolol; Regional Blood Flow; Vascular Resistance | 1982 |
Comparison of HT29-18-C1 and Caco-2 cell lines as models for studying intestinal paracellular drug absorption.
Topics: Atenolol; Biological Transport; Caco-2 Cells; Cell Division; Cell Membrane Permeability; Cimetidine; HT29 Cells; Humans; Hydrochlorothiazide; Intestinal Absorption; Mannitol; Ranitidine; Tritium | 1996 |
Stereoselective permeation of new fluorinated quinolone derivatives across LLC-PK1 cell monolayers.
Topics: Animals; Anti-Infective Agents; Biological Transport; Cations; Cell Membrane Permeability; Cimetidine; Dose-Response Relationship, Drug; Drug Interactions; Guanidine; Kidney; Levofloxacin; LLC-PK1 Cells; Mannitol; Ofloxacin; Stereoisomerism; Swine; Tritium | 1999 |
Effects of cimetidine and its metal complexes on nitroblue tetrazolium and ferricytochrome c reduction by superoxide radicals.
Topics: Cimetidine; Copper; Cytochrome c Group; Dose-Response Relationship, Drug; Edetic Acid; Mannitol; Metals; Nitroblue Tetrazolium; Oxidation-Reduction; Superoxides | 1999 |
Transport of procainamide via H(+)/tertiary amine antiport system in rabbit intestinal brush-border membrane.
Topics: Amines; Animals; Biological Transport; Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone; Cimetidine; Ethylamines; Guanidine; Hydrogen-Ion Concentration; Intestinal Mucosa; Intestine, Small; Kinetics; Male; Mannitol; Microvilli; Potassium; Procainamide; Rabbits; Sodium | 2000 |
Analysis of drug transport and metabolism in cell monolayer systems that have been modified by cytochrome P4503A4 cDNA-expression.
Topics: Animals; Atenolol; Biological Transport; Cell Line; Cell Membrane Permeability; Cimetidine; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; DNA, Complementary; Erythromycin; Glucose; Humans; Mammals; Mannitol; Mixed Function Oxygenases; Pharmaceutical Preparations; Phenylalanine; Propranolol; Recombinant Proteins; Testosterone; Tumor Cells, Cultured; Verapamil | 2000 |
A new approach to predict human intestinal absorption using porcine intestinal tissue and biorelevant matrices.
Topics: Animals; Atenolol; Caco-2 Cells; Cimetidine; HT29 Cells; Humans; Intestinal Absorption; Intestinal Mucosa; Jejunum; Mannitol; Permeability; Ranitidine; Swine; Tumor Cells, Cultured | 2014 |